Viking Therapeutics Is Having a Year to Remember: Time to Buy?

Viking Therapeutics Today VKTX Viking Therapeutics $64.45 +1.51 (+2.40%) 52-Week Range $8.28 ▼ $99.41 Price Target $108.60 Add to Watchlist Viking Therapeutics Inc. NASDAQ: VKTX, a clinical-stage biotechnology company with a market cap approaching $7 billion, is turning heads in 2024. Year to date, the stock has surged an impressive 238%, and its rise over the past 12 months has been even more dramatic, with shares climbing 326%. For a mid-cap biotech, these kinds of gains significantly outpace both the bro ...